| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b331f92a455bc609caacfe7ba10edab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 |
| filingDate |
2007-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4947ff2345a6680ec4cc15947cbd5b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c00343c3f01240e247c5761140e26658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76e326bfb88dae7b7dbd2ecdb4cbf291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88cee4c30143fdf02a4e412fbf087903 |
| publicationDate |
2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1996246-B1 |
| titleOfInvention |
Taxane coatings for implantable medical devices |
| abstract |
This disclosure relates to implantable medical devices coated with a taxane therapeutic agent, such as paclitaxel, in one or more solid form(s) having varying dissolution rates. Particularly preferred coatings comprise amorphous and/or solvated solid forms of taxane therapeutic agents that provide durable coatings that release the taxane over a desired period of time, which can be varied in the absence of a polymer by selecting the type and amount of solid forms of the taxane therapeutic agent in the coating. Other preferred embodiments relate to methods of coating medical devices and methods of treatment. The coatings can provide a sustained release of the taxane therapeutic agent within a body vessel without containing a polymer to achieve the desired rate of paclitaxel elution. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8669360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9056152-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8597720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9192697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889211-B2 |
| priorityDate |
2006-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |